Abstract
After the introduction of routine treatment for every nasal carrier of methicillin-resistant Staphylococcus aureus, active follow-up surveillance for nosocomial methicillin-resistant S. aureus infection was conducted for 5 years in an intensive care unit of a tertiary-care teaching hospital. There was a significant decrease in the incidence of nosocomial methicillin-resistant S. aureus infection during the later years of follow-up. Decolonization of nasal carriers of methicillin-resistant S. aureus is probably associated with such findings.
MeSH terms
-
Anti-Bacterial Agents / administration & dosage*
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Infective Agents, Local / administration & dosage*
-
Anti-Infective Agents, Local / therapeutic use
-
Brazil
-
Chlorhexidine / administration & dosage*
-
Chlorhexidine / therapeutic use
-
Cross Infection / prevention & control
-
Humans
-
Infection Control / methods
-
Intensive Care Units*
-
Methicillin Resistance*
-
Mupirocin / administration & dosage*
-
Mupirocin / therapeutic use
-
Nose / microbiology*
-
Ointments
-
Staphylococcal Infections / epidemiology*
-
Staphylococcal Infections / prevention & control
-
Staphylococcus aureus* / drug effects
Substances
-
Anti-Bacterial Agents
-
Anti-Infective Agents, Local
-
Ointments
-
Mupirocin
-
Chlorhexidine